1 Polycystic Kidney Disease: Diagnosis and Treatment By Jennifer R. Frost RN, BSN, CNN A Manuscript submitted in partial fulfillment ofthe requirement for the degree Master OfNursing Washington State University Intercollegiate College ofnursing Spokane, Washington December 2002
2 11 To the faculty ofwashington State University: The members ofthe committee appointed to examine the Intercollegiate College of Nursing research requirements and manuscript ofjennifer RACHEL FROST fmd it satisfactory and recommend that it can be accepted. Lorna Schumann, PhD, FAANP, ARNP a M~uld Bruya, DNSC, ARNP, FAAN Dr. Curtis G. Wiekre, MD, FAAP
3 III Acknowledgements I would like to thank everyone who has supported me in one way or another in completing this manuscript and fulfilling my goals in pursuit ofmy chosen profession. My gratitude goes out to those who graciously served on my committee for this clinical project. Dr. Margaret Bruya, committee member, who, at the beginning, served as my advisor and guided me through the difficult time ofgoing back to school after eleven years. Having gone to nursing school outside the United States, I was unaware ofwhat to expect and the challenges that I would have to face. Margaret made it easy to venture back into the academic portion ofthe program. Dr. Lorna Schumann, committee member and mentor. Lorna has always been available to help with any questions I may have. She has been a great example ofwhat an exemptional Nurse Practitioner and educator should be. Dr. Curtis Wickre who has been a wonderful resource and mentor. Knowing how occupied he is with the many responsibilities that come with his profession, he has given his tinle and energy with a considerable amount ofregard and attention to educate and guide me through this process. Finally, I would like to thank my husband, Richard, and daughter, China who have been understanding and supportive throughout this educational experience. They were there to share my frustrations, fears as well as my triumphs and accomplishments. I could not have done it without their reassurances and encouragement.
4 IV Abstract Polycystic Kidney Disease By Jennifer Rachel Frost Washington State University, December 2002 Chair: Dr. Lorna Schumann Cystic kidney disease describes several conditions in which fluid-filled cysts form in the kidneys. Polycystic Kidney Disease or PKD is the most common, life-threatening genetic disease (Breuning & Peters, 2001). These cysts can grow so large and numerous rendering the kidneys unable to function normally. Screening individuals at risk is important especially with regards to reproduction. There is no cure for PKD. Treatment options include medications or surgery for pain control, management ofhypertension and treatment ofinfection. Dialysis is usually necessary at end-stage renal disease. Kidney transplantation is also an option for persons with advanced PKD. It is important that health care providers recognize the implications ofthis disease. Referral to a nephrologist should be done in a timely manner.
5 v Table of Contents Title Page Signature Page Acknowledgements Abstract Table of Contents List of Tables List of Figures Introduction Definition and Pathophysiology Pathogenesis ofcyst formation and growth Progression to renal failure Clinical Features Diagn.osis Differential Diagnosis Sensitivity and specificity Cost Effectiveness Treatment Plan. Conclusion Table 1 Table 2 Table 3 Table 4 Table 5 i ii iii iv v vii viii
7 VII List of Tables Table 1 Types of PKD 24 Table 2 Bosniak. classification system 25 Table 3 Requirements for a positive diagnostic imaging 26 Table 4 Patient preparation for radiographic examinations 27 Table 5 Differential Diagnosis 28 Table 6 Sensitivity and specificity ofdiagnostic exams for PKD 29 Table 7 Charges for diagnostic exams for PKD 30 Table 8 Simple cyst vs. renal CA vs. PKD 31
8 VIII List of Figures Figure 1 PKD patients with ESRD in the US 32 Figure 2 Incident counts ofreported ESRD patients by primary diagnosis from Figure 3 Cut surface ofkidneys with recessive polycystic kidney disease (ARPKD) 34 Figure 4 Retroperitoneum ofan adult with dominant polycystic kidney disease (ADPKD) 35 Figure 5 Cut surface ofan enlarged kidney from an adult with ADPKD 36 Figure 6 Polycystic kidney disease involving one kidney 37 Figures 7 and 8 Gadolinium-enh.anced scans 38 Figure 9 Simple renal cysts 39 Figure 10 NOnIlal fetal kidneys 40 Figure 11 PKD patients with ESRD in Washington state 41 Figure 12 Algori"thm 42
10 1 Introduction The renal cystic disorders include a relatively large group ofdiseases typified by the formation ofone or more fluid filled cavities within the kidneys. These cavities, or cysts, may arise in all parts ofthe kidney. In their formative stage, they may be slightly larger than a single nephron structure, which is a few microns in diameter, or they may be so large as to compress the abdominal viscera (Fick & Gabow, 1994). Renal cysts may be idiopathic; they may compromise renal function and cause renal failure, may be associated with non-renal disorders, may be acquired, and may be precursors ofmalignancy. Confusion has arisen because the terminology used to describe this large group ofdiseases is imprecise at times and multiple cysts do not necessarily denote a heritable condition or a specific syndrome. Polycystic kidney disease (PKD) is one ofthe most common hereditary disorders, affecting 12 to 15 million people worldwide, a number greater than the combined number ofthose with cystic fibrosis, sickle cell anemia, muscular dystrophy, hemophilia and Down's syndrome (Gardner & Grantham, 1985). Medical care costs for diagnosis and treatment exceeds $200 million a year (Gabow, 1993). The cysts are presumed to be what directly or indirectly cause the symptoms that are characteristic ofthe disease. Though they start out microscopic in size, averaging 3-5 mm. in diameter, some ofthese cysts can become quite large, up to 10 cm. and contain several hundred cc's offluid (Bayrak-Toydemir & Pergament, 2001). PKD affects all ages, races and sexes. More than 600,000 Americans are affected by the disease [(See Figure 1) (Bhandari, Brownjohn, Eardley, Dedi & Turney, 2001)]. It is the fourth leading cause ofkidney failure (See Figure 2). Significant proportions ofpersons who carry the gene for PKD are not aware ofit nor do they have suggestive symptoms. Therefore, persons may have PKD for years before it is diagnosed (Gardner & Grantham, 1985, Gabow, 1993).
11 2 There are two genetically different types ofpkd namely, Autosomal Recessive PKD (ARPKD or sometimes called "Infantile PKD") and Autosomal Dominant PKD (ADPKD often called "Adult Onset PKD"). Autosomal recessive PKD requires a defective gene from both parents, and is thus, much more uncommon. The autosomal recessive PKD gene has been identified on chromosome 6 (Bayrak-Toydemir & Pergament, 2001). Although only an estimated one in every 10,000 to 20,000 children is born with the disorder, the odds of developing it are one in four when both parents carry the gene (De Bruyn & Gordon, 2000). A child born with autosomal recessive PKD usually dies within the first one or two months oflife. The children who survive need a transplant by grade school. Sometimes, the condition may not present until adult life, and even then, the hepatic component ofthe disease may be the most prominent feature. Cysts usually occur at a later age in autosomal dominant PKD, yet it has been noted to occur in younger subjects at risk, thus, making "autosomal dominant PKD" a more appropriate designation than "adult onset PKD" (Gardner & Grantham, 1985). Children offamilies affected with autosomal dominant PKD have a 50% chance ofinheriting the disease. In children, the most helpful information in differentiating autosomal recessive PKD from autosomal dominant PKD is the presence ofbilateral renal cysts in one parent (Gabow, 1993). There is a correlation between symptom severity, age of symptom onset, and the gene location involved (see Table 1). There are at least three, and maybe more genes that can cause autosomal dominant PKD. The first gene called PKD1 has been found on chromosome 16 and accounts for about 85 to 90% of known autosomal dominant PKD patients. Tile mean age ofonset ofend-stage renal disease (ESRD) is 53.0 years in PDKI.
12 3 The second gene known as PKD2 has been linked to chromosome 4, and accounts for 5 to 15% ofknown autosomal dominant PKD cases. Patients with PKD2 are free ofsymptoms 75% ofthe time and only 7.5% progress to ESRD. PKD2 is said to be clinically milder, with symptoms presenting later in life, and is associated with living longer and having a lower risk of progressing to renal failure and complications. The mean age for ESRD is 69.1 years in PKD2 (Arnaout, 2001, Hateboer, Dijk, Bogdanova et al., 1999). In approximately 25 to 40% ofcases, PKD occurs in people without a family history ofthe disease. This can represent a new mutation, or more often, particularly in non-pkdl families, result from such slow progression that affected family members die from other causes before there are any manifestations ofpkd (http://www.utdol.com). The third gene is called PKD3, but no genomic locus has been found. The difference in gene defect location does not completely account for the variability seen in autosomal dominant PKD since a variation in severity is also seen within the same family, where presumably one would expect similar disease outcomes. Health care providers should advise their patients about the availability ofprenatal screening and the importance ofscreening asymptomatic relatives for the purpose ofidentifying individuals at risk and aid in making informed medical decisions concerning long-term prognosis (Berner & Nates, 2001). Definition and Pathophysiology PKD is an abnormal condition in which the kidneys are enlarged and contain many cysts, which are sacs offluid. It is a systemic disorder characterized by cyst formation in ductal organs, and by gastrointestinal, cardiovascular and musculoskeletal abnormalities (Gabow, 1993). Autosomal recessive PKD typically presents in infancy, although there are childhood and adolescent forms that are generally less severe (See Figure 3). The disease is usually discovered
13 4 neonatally or perinatally. Documentation offetal renal cysts during pregnancy will not predict the clinical course (Gabow, 1993). About 60% ofaffected children die within the first month of life, and in those that live past one month, the mean survival is approximately six years (Berner & Nates, 2001). Hypertension, edema, impaired liver and kidney function, and frequent urinary tract infections are prevalent in autosomal recessive PKD. Affected children are at risk for hepatic fibrotic disease and are treated with dialysis and renal transplantation when ESRD occurs (Berner & Nates, 2001). Death is usually secondary to renal failure (Levine et ai., 1997). Autosomal dominant PKD is hard to overlook (See Figure 4 and 5). In the fully developed state, the kidneys are massively enlarged. Autosomal dominant PKD is usually recognized clinically after the childbearing period, and the defective gene relish nearly complete penetrance, thus ensuring a steady number ofaffected patients. These patients suffer in several respects. The disease causes renal failure in about 50% ofaffected patients, an awareness that is causing unending stress in young patients at risk (Gardner & Grantham, 1985). Cerebral aneurysms are found in a significant proportion ofpatients with autosomal dominant PKD, and their rupture can lead to sudden death in an otherwise asymptomatic vigorous person (Bayrak-Toydemir & Pergament, 2001). Damage to the kidneys is caused by structural deformities caused by the enlarging cysts, as well as by elevations in blood pressure. Cysts can also form in other organs such as the liver and pancreas (Levine et al., 1997). At one point, it was thought that as the cysts grew, they simply crowded out the healthy kidney cells. However, researchers are looking at other interactions between cystic cells and their neighboring normal kidney cells to suggest a definitive basis for renal failure (Gardner & Grantham, 1985).
14 5 Pathogenetic theories ofcyst formation and growth The genetic locus ofautosomal dominant PKD (PKD1) is located on the short arm of chromosome 16 which encodes a large protein, polycystin, the exact function ofwhich is not yet known (Arnaout, 2001). It is thought that this resulted in mislocation ofthe Na+/ K+ - ATPase pump to the apical surface, where epidermal-growth-factor receptors are located, instead ofthe basolateral cell surface ofthe kidney, such that fluid is secreted only into the cyst contributing to its growth (Gabow, 1993, Arnaout, 2001). The genetic locus ofautosomal dominant PKD2 (PKD2) is located on long arm ofchromosome 4, which also encodes a protein homologous to polycystin (Arnaout, 2001). Tubular lumen destruction theory Several theories have been suggested that contribute to cyst formation. Autosomal dominant PKD cysts are heterogeneous in size, and lined by a single layer ofepithelium. Arnaout (2001) stated that cysts begin as focal ballooning oftubules with a majority losing tubular connection altogether. In this theory, obstructions oftubular lumen arise from early focal tubular dilation producing a retrograde increase in intraluminal pressure from either epithelial proliferation or an abnormally compliant basement membrane (Gabow, 1993, Woo, 1995, Arnaout, 2001, Calvet & Grantham, 2001). In many respects, the cyst's epithelium also behaves as a benign neoplastic tissue. Endogenous growth factors, hormones, and cytokines may influence the growth ofthese cysts, as well as a decreased response to inhibitors ofproliferation (Gabow, 1993, Arnaout, 2001, Calvet & Grantham, 2001). Basement membrane theory A second theory is that abnormally compliant basement membranes are thought to be present on a genetic basis, since there are some biochemical and functional differences from normal
15 6 nephrons. The basement membrane changes also preceed tubular cell proliferation (Woo, 1995, Arnaout, 2001). Extracellular matrix theory Another theory is that the extracellular matrix is altered early in the course ofrenal cystogenesis, but it has not yet been possible to determine whether the cell proliferation or the matrix abnormality is the primary event coded by the mutated gene (Calvet & Grantham, 2001). The matrix abnormality ultimately leads to interstitial inflammation and fibrosis and it is these factors that may decide whether or not renal function is irreversibly compromised (Gardner & Grantham, 1985, Gabow, 1993, Woo, 1995). In addition, the systemic abnormalities associated with PKD are compatible with a defect in the composition ofthe extracellular matrix (Gabow, 1993). "Double-hit" theory Yet another theory suggests a "double-hit" mechanism for PKD cyst formation. The "first hit" is the mutation ofthe PKD gene inherited from a parent who has PKD. The "second hit" occurs in individual epithelial cells ofthe kidney. Each cyst forms as a result ofa newly acquired mutation in a single clone from a kidney epithelial cell (Calvet & Grantham, 2001, Arnaout, 2001). The high rate at which "second hits" must occur to account for the large number ofcysts observed suggests that unique structural features ofpkd genes may be responsible for its mutability. A portion ofthe PKD gene is believed to cause the formation ofa triple helix structure. Triple helix structures have been shown in other studies to cause increased mutations (Germino, 1997). The "double-hit" process may explain the wide variation in PKD severity seen within families, where affected individuals have the same mutation and might otherwise be expected to exhibit similar severity ofthis disease (Calvet & Grantham, Germino).
16 7 Still, independent variables such as increased levels ofcyclic AMP, increased levels of angiotensin II, increased Na+/ K+ - ATPase activity, and potassium depletion, are thought to stimulate cellular proliferation. Therefore, modification ofthese potential stimulants by certain therapeutic maneuvers may delay cellular proliferation (Gardner & Grantham, 1985, Torres, Young, Offord & Hattery, 1990, Calvet & Grantham, 2001). Since only about 10% ofall nephrons have cysts and since only 15-30% ofcysts have a connection with their parent nephron, these cysts must grow by means other than filtration. Fluid is said to accumulate in cysts via two mechanisms. In a morphologic study ofan individual cyst, it was noted that as the cyst grew, it detached from its tubular connection allowing it to be isolated from the glomerulus (Calvet & Grantham, 2001). The cyst then fills with glomerular filtrate that escapes reabsorption by tubule segments afferent to the cyst (Gabow, 1993). However, in most cysts, fluid accumulates due to the active transport ofsodium chloride (NaCI) resulting from the abnormal location ofthe Na+/ K+ - ATPase pump in cystic epithelium (Gabow, 1993). This secretion is apparently modulated by signal transduction processes, one ofwhich involves stimulation ofthe intracellular production ofcyclic AMP (Gardner & Grantham, 1985, Ye & Grantham, 1993, Calvet & Grantham, 2001). Thus, fluid is moved into the cyst cavity, rather than out ofit by osmosis (Gabow, 1993). Cysts were also observed to not only absorb fluid, but secrete them as well (Arnaout 2001). Ye and Grantham (1993), as well as Grantham et al. (1989) concluded in their studies that cysts from patients with PKD can secrete fluid from within, and can be increased in size by unidentified secretagogues in the cyst fluid, suggesting cyst enlargement susceptibility to pharmacologic intervention. This fluid secretion was apparently coupled to the active transport
17 8 ofsolutes, which is consistent with the hypothesis that camp is an important intermediary promoting increased transport offluid (Calvet & Grantham, 2001). Progression to Renal Failure Several possibilities have been suggested to explain the progressive deterioration ofrenal function in PKD patients. Factors related to progression are gender, history and hypertension. Progressive arteriolar lesions and pressure from enlarging cysts may lead to atrophy of surrounding tissue and interstitial fibrosis (Ritz, Geberth, Zeier & Waldherr, 1993). Secondary environmental factors may trigger cell growth and more cyst formation. Infection and associated endotoxin might enhance cyst growth in genetically susceptible animal host. Apoptosis or programmed cell death may be enhanced in cystic and non-cystic parts ofautosomal dominant PKD kidneys (Woo, 1995, Amaout, 2001, Calvet & Grantham, 2001). Uncompensated apoptosis and the inability to regenerate new nephrons would then result in progressive loss of renal tissue. Clinical Features In the early stages ofpkd, many people with the disease show no symptoms. As PKD progresses, symptoms may gradually start to develop such as hypertension, fatigue, frequent urination, headaches, or urinary tract infections and low back or flank pain. On the average, patients begin to notice these symptoms, somewhere between ages 20 and 40 (Breuning & Peters, 2001). Somehow, females have a slower rate ofdecline in glomerular filtration rate (GFR) in early renal insufficiency, compared to males. However, once GFR fell below 25 ml/min per 1.73 m2, the rate ofdecline ofgfr was equivalent in males and females (National Institute ofdiabetes, Digestive and Kidney Diseases, National Institute ofhealth [NIDDKD, NIH], 1995). This fmding was supported by Choukroun et al. (1995), who also stated in their
18 9 report that the age at ESRD in male patients was lower when the disease was transmitted by mother than by father, while no significant effect ofthe gender ofthe affected parent was apparent in female patients. Abdominal or flank pain is the most common symptom ofautosomal dominant PKD. Pain may be caused by cyst hemorrhage, a renal calculi usually resulting from cyst hemorrhage or urinary stasis, and rarely, pain is caused by a renal tumor. Non-renal causes ofpain such as diverticular disease, or ruptured abdominal aortic aneurysm must be considered to minimize the risk offurther renal damage during therapeutic measures. The pain from polycystic kidneys is often described as dull, nagging or aching; however, it can be colicky. Differentiation among these complications is important for management purposes (Gardner & Grantham, 1985). When the disease becomes more advanced, it begins to noticeably affect several internal organs. In patients with diffuse bilateral cysts ofthe kidney, the presence ofliver cysts is virtually pathognomonic ofautosomal dominant PKD. Cysts develop in the liver in about 60% ofpkd patients, but the liver itselfalmost never fails because ofthem (Levine et al., 1997). In a few patients, renal enlargement can cause chronic pain due to the size and location ofthe cysts. The pancreas develops cysts in about 10% ofpkd patients, but almost never causes problems. Incidence ofovarian cysts related to autosomal dominant PKD is unknown (Gabow & Fick, 1994). Non-cystic manifestations involve several organ systems as well. The heart's mitral valves weaken resulting into prolapse in about 26% ofpkd patients. An enlarged heart is common in older individuals possibly from prolonged hypertension. Moreover, angiotensin, which is a major mediator ofhypertension, may affect the growth ofcysts, which will eventuate in the compression ofsurrounding renal parenchyma by the cysts (Gabow, 1993). Intracranial
19 10 aneurysms, one ofthe most devastating extrarenal manifestation ofpkd, occur anywhere from 0 to 41% ofpkd patients (Bayrak-Toydemir & Pergament, 2001, Ferri, 2003 Gabow, 1993) supporting the theory ofhaving an abnormal extracellular matrix or perhaps an altered cerebral vascular reactivity in PKD (Gabow, 1993). The principal non-cystic gastrointestinal manifestation is colonic diverticula, the pathogenesis ofwhich includes a component of abnormal extracellular matrix, which again, further supports a role for such an abnormality in PKD (Gabow, 1993). In the final stages ofpkd, the major symptom is loss ofkidney function. By this time, numerous cysts have formed throughout both kidneys and have grown to a point where they are crowding out, or causing destruction ofnormal or non-cystic kidney tissue (De Bruyn & Gordon, 2000). As this occurs, the kidneys loose their ability to filter blood. ESRD is characterized by symptoms that result from the inability ofthe body to filter out waste products from the blood, leading to uremia (Bayrak-Toydemir &Pergament, 2001). The degree and time ofonset ofsymptoms ofpkd can vary greatly from one family to the next and can also vary within families. This makes it difficult to determine beforehand what an individual's PKD course will be like (Breuning & Peters, 2001). The younger a patient is diagnosed with polycystic kidney disease, the earlier end-stage renal disease is likely to develop (http://www.utdol.com).becauseofthehighvariabilityofpkd.itis difficult to identify when someone will reach ESRD. Some people reach this stage very early in their lives and others may never loose all oftheir kidney function, even ifand when they reach the age of 80 or more. ESRD is treatable through dialysis or transplantation. Unfortunately, neither ofthese treatment options cures the disease (Gardner & Grantham, 1985).
20 11 Diagnosis Cystic renal disease is a wide spectrum ofconditions and imaging forms a crucial aspect in the evaluation ofthe client. The ultimate diagnosis ofcystic kidneys requires clinical, genetic, radiological and pathological information. A precise diagnosis is important for prognosis, treatment and genetic counseling, although this may not be possible at presentation (Bayrak Toydemir & Pergament, 2001). Affected patients typically present with a positive family history, flank pain or renal insufficiency, and large kidneys with multiple bilateral cysts on ultrasonography or CT scanning [(see Figures 6, 7 and 8) (Higgins & Fitzgerald, 2001)]. There are three ways to diagnose PKD: ultrasound, computed tomography, or magnetic resonance imaging (Levine et ai., 1997). Ultrasound is valuable in many circumstances. There are situations where physicians cannot get information in any other way, such as with pregnant women and there are no side effects to ultrasound (Bayrak-Toydemir & Pergament, 2001). Ultrasound is the most reliable, inexpensive and non-invasive way to diagnose PKD (Gabow, Ikle & Holmes 1984, Bayrak-Toydemir & Pergament). However, other conditions require integration ofmany imaging modalities, when certain conditions are being considered, such as distinguishing between autosomal dominant PKD versus tuberous sclerosis in a young child. Similar imaging features may be seen in more than one condition and appearances may change with time stressing the need for a comprehensive imaging work-up at presentation and at follow-up (De Bruyn & Gordon, 2000). Occasionally, a CT scan may detect smaller cysts that cannot be found on ultrasound (Basaria & Mehta, 2000, Bayrak-Toydemir & Pergament 2001). In some institutions, the abdominal CT scan has become the screening test for severe abdominal pain when renal stones, appendicitis, or diverticulitis is suspected. Delayed reactions are exceedingly rare. For urgent studies, the results
21 12 should be known in a relatively short period oftime (Higgins & Fitzgerald, 2001). Computed tomography has been reported to be more sensitive than ultrasonography, particularly for complications ofpkd. It is advisable to use CT in persons in whom ultrasound findings are suspicious, but do not yield a conclusive diagnosis (Gabow, IIde & Holmes, 1984, Levine, et ai., 1997). In 1986, a radiologist named Bosniak proposed a classification system (see Table2) to serve as a point ofreference in the diagnosis, classification, and characterization ofcystic lesions (Leder, 1999). The classification system is a 4-part categorization for cystic renal masses, based on CT fmdings. The Bosniak classification appears to be the best system currently available for the noninvasive classification ofcystic renal masses (Leder, 1999). For the routine evaluation ofrenal masses, MRI currently carries no significant advantage over CT scan (Leder, 1999). In certain situations, however, such as a patient with contrast material allergy, an elevated serum creatinine level or a hyperdense renal cyst, MRI is either safer or more accurate than CT scan. Additionally, MRI can assess venous involvement in renal cell carcinoma (Wolf, 1998). At present, PKD cannot be diagnosed by a single blood test. However, in some situations where it is important to have a diagnosis, as in potential living related kidney donor evaluation, and ultrasound and CT scans are normal, gene linkage analysis can be done to determine a definitive diagnosis in the at-risk individual. It is done by flanking DNA probes that are adjacent and tightly linked to the PKD1 gene locus on chromosome 16. This technique, which is available in certain molecular diagnostic and genetics laboratory, has greater than 99% accuracy for PKD1 and can be performed prior to radiologically evident cysts. The DNA test will also allow effective prenatal testing for those ofprocreative age who carry the diseased gene and
22 13 might wish to have genetic counseling in order to make decisions about reproduction (De Bruyn & Gordon, 2000, Bayrak-Toydemir & Pergament, 2001). With this comes a need to assess the psychological impact on patients' families. The early testing of individuals at-risk can establish a diagnosis years before symptoms appear. These linkage studies will not detect non-pkdl disease. Identification ofthe PKD1 gene may be replaced in the future by direct analysis ofthe gene (http://www.utdol.com). The CRISP study (Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease) is now underway involving three centers; the Mayo Clinic, Emory University Medical Center and the University ofkansas Medical Center. New imaging techniques involving magnetic resonance imaging (MRI) have been developed that will be able to detect small changes in renal size, as well as cyst growth, and to detect cysts smaller than have been detectable by conventional ultrasound techniques. This would allow for therapeutic interventions such as new pharmacologic therapies to be tested in individuals over a much shorter period oftime than previously anticipated (http://www.pkdcure.org). Differential Diagnosis It is necessary to differentiate PKD from a simple cyst or renal carcinoma. Simple renal cysts are the most common cystic abnormality encountered in human kidneys (See Figure 9). Simple cysts are a frequent random observation on ultrasound or with CT scanning. They may be solitary or multiple. A single layer of flat epithelium lines the wall of simple cysts and the cyst fluid is chemically similar to an ultrafiltrate ofplasma. Autopsy studies indicate that one or more cysts may be present in one-half ofpersons greater than 50 years ofage. The prevalence of simple cysts increases with age, especially in males (Ravine, Gibson, Donlan & Sheffield, 1993). These cysts are rarely infected and are not associated with decreasing renal function. Hematuria
23 14 is a rare complication ofsimple renal cysts, and, ifobserved, should prompt the suspicion of renal cell carcinoma (Levine et al., 1997). Sonographic diagnosis ofpossible autosomal dominant PKD in those known to be at 50% risk due to a positive family history varies with age (see Table 3). Concurrent complicating renal cell carcinoma is uncommon (Arnaout, 2001) Sensitivity and specificity DNA analysis is the gold standard for the diagnosis ofautosomal dominant PKD, especially in people less than 20 years ofage. Onset ofclinical disease is relatively uncommon in young children, and screening is most often performed in subjects over the age of20 (http://www.utdol.com). Ultrasound and computed tomography are accurate methods for diagnosis ofpkd; however, the ability to diagnose quickly and noninvasively both renal and associated extrarenal involvement makes ultrasound the procedure ofchoice for diagnosis, screening, and follow-up (Lawson, McClennan & Shirkhoda, 1978). Cysts, as small as one to one and a halfcentimeter in diameter can be detected by ultrasonography and halfa centimeter by CT scanning. Standard guidelines for diagnosing in patients with a family history ofautosomal dominant PKD require bilateral involvement with a total ofat least three to five cysts. This criterion may be too stringent for young children and too lax in older patients who may have multiple simple cysts. A study in which ultrasonography was correlated with DNA linkage for the PKD1 gene suggested that the criteria used should be modified for age to minimize both false negative and false positive results (http://www.utdol.com). Ultrasound diagnosis is highly dependent on age. Under the age of30, ultrasound imaging method is not recommended as a routine diagnostic procedure because ultrasound may not depict cysts smaller than one centimeter. Although ultrasound has a reported sensitivity of93% for
Renal Cysts What should I do now? Dr Edmund Chiong Asst. Professor & Consultant Department of Urology National University Hospital What are renal cysts? Fluid-filled structures in the kidney that are not
Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis
Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.
Online Slide/Audio Symposium 10th Annual Conference on Polycystic Kidney Disease, June 1999. Selected Talks. Web presentation sponsored by an unrestricted educational grant from Sigma-Tau Pharmaceuticals
Volume Article.13-11 Publish Date: 24th June 2013 Author(s): MPUH - CRS Team Four Important Facts about Kidney Cancer ARTICLE hhh Muljibhai Patel Urological Hospital (MPUH) Centre For Robotic Surgery (CRS)
James Whale Fund for Kidney Cancer Childhood kidney cancer factsheet Kidney cancer rarely afflicts children and about 90 paediatric cases are diagnosed in the UK each year. About 75% of childhood kidney
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
Chronic Kidney Disease Introduction Chronic kidney disease, also known as CKD, is the gradual loss of kidney function. When CKD reaches an advanced stage, dangerous levels of fluid, electrolytes and wastes
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
Bladder Stones A DNA test for Hyperunicosuria (HUU) to find the gene which is implicated in the development of URATE stones has been developed which work with Bulldogs and many other breeds including Black
Understanding NICE guidance Information for people who use NHS services Identifying and treating long-term kidney problems (chronic kidney disease) NICE clinical guidelines advise the NHS on caring for
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
DIALYSIS COMPACT The function, diseases and treatments for the human kidney. Content 3 Editorial 4 What do healthy kidneys accomplish? 5 What causes kidney disease? 6 What effects does kidney disease have?
CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES Reviewed and approved 5/2014 Risk Chronic kidney disease is defined as either kidney damage or decreased kidney function (decreased GFR) for 3 or more months.
What is chronic kidney disease or failure? Chronic Kidney/Renal Disease Kidney disease means that something is abnormal about the structure or function of one or both kidneys. Most often, kidney disease
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
This lecture is drawn from the continuing medical education program Finding Hope: Prevention, Early Detection and Treatment of Pancreatic Cancer, Nov, 2011. Robert P. Jury, MD Cystic Neoplasms of the Pancreas:
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
Cystic Fibrosis What is cystic fibrosis? Cystic fibrosis (CF) is an inherited disease characterized by an abnormality in the glands that produce sweat and mucus. It is chronic, progressive, and is usually
1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor
Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years
Urinary Tract Infections in Adults Urinary tract infections (UTIs) are responsible for more than seven million visits to physicians' offices per year and about 5 five percent of all visits to primary care
NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National
Obstetrical Ultrasound and Prenatal Diagnostic Center Prenatal Diagnosis: Options and Opportunities Learn about various screening options including Early Risk Assessment (ERA), now available to women of
What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,
MRI for cervical radiculopathy Referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: cervical radiculopathy
HOW TO CARE FOR A PATIENT WITH DIABETES INTRODUCTION Diabetes is one of the most common diseases in the United States, and diabetes is a disease that affects the way the body handles blood sugar. Approximately
Liver Cancer What is the liver? The liver is the largest internal organ in the body and is important in digesting food. The liver performs many other functions, including collecting and filtering blood
Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of
Patient Information Genetic Testing for Childhood Hearing Loss Introduction This document describes the most common genetic cause of childhood hearing loss and explains the role of genetic testing. Childhood
WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS This is a patient information booklet providing specific practical information about gall bladder polyps in brief. Its aim is to provide the patient
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
High Blood pressure and chronic kidney disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
A PATIENT S GUIDE TO ABLATION THERAPY THE DIVISION OF VASCULAR/INTERVENTIONAL RADIOLOGY THE ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL Treatment options for patients with cancer continue to expand, providing
Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Behçet s Disease and the Kidneys How are the kidneys affected by Behçet s disease? Kidney disease
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
s Preventive Care Services Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet What do the kidneys do? Your kidneys have important jobs to do in your body. Two of the kidneys most important jobs
Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan
What is kidney cancer? Renal cell carcinoma (RCC) is the most common kind of kidney cancer. 1 Normally, your kidneys filter your blood and excrete waste in urine. Although our kidneys are important, we
Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,
Understanding Pancreatic Cancer Understanding Pancreatic Cancer The Pancreas The pancreas is an organ that is about 6 inches long. It s located deep in your belly between your stomach and backbone. Your
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
Duchenne muscular dystrophy (DMD) What is Duchenne muscular dystrophy or DMD? Muscular Dystrophy is a group of inherited muscle disorders, in which muscles weaken over time. Duchenne muscular dystrophy
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
Your Kidneys: Master Chemists of the Body www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease Outcomes
1333 Plaza Blvd, Suite E, Central Point, OR 97502 * www.mountainviewvet.net Diabetes Mellitus (in cats) Diabetes, sugar Affected Animals: Most diabetic cats are older than 10 years of age when they are
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
FALL TERM COURSES: Master of Physician Assistant Studies Course Descriptions for Year I PHAC 7230 Fundamentals in Pharmacology for Health Care I Credit Hrs: 3 This course will build on foundational knowledge
PKD PATIENT S MANUAL: Understanding & Living with Autosomal Dominant Polycystic Kidney Disease Originally Created by: Irene Duley, RN ANP Patricia Gabow, MD University of Colorado Health Sciences Center
FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies Raymond A. Huml, MS, DVM, RAC Executive Director, Head, Global Biosimilars Business Development and Strategic Planning, Quintiles
LIVING DONATION What You Need to Know www.kidney.org 2 NATIONAL KIDNEY FOUNDATION TABLE OF CONTENTS About Living Donation.... 4 The Evaluation Process.... 6 Surgery and Recovery.... 12 After Donation....
Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Kidney Transplant Candidate Informed Consent Education Here are educational materials about Kidney Transplant. Please review and read these before your evaluation visit. The RN Transplant Coordinator will
Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
American Kidney Fund reaching out giving hope improving lives Diabetes and Your Kidneys reaching out giving hope improving lives Diabetes: The #1 Cause of Kidney Failure Your doctor told you that you have
ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the
Positron Emission Tomography - For Patients A physician s written order is required for any PET-CT tests. How should I prepare for my PET-CT? PET-CT is more complicated than most other tests you may be
The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) QUEENSWAY CARLETON HOSPITAL DIVISION OF UROLOGY NEPEAN, ON, CANADA Disclosures None Objectives Advances in the field of Renal Cell
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD With the widespread use of cross-sectional imaging, many renal masses are incidentally found. These need to be accurately
GENERAL: Breast Cancer Toolkit Marion DePuit, MSN, Faith Community Nurse Leslie Brown, BA, Community Advocate 9/2014 Understanding Breast Cancer (Adapted from the American Cancer Society and Breast Cancer.org)
Other Noninfectious Diseases Chapter 31 Lesson 3 Diabetes Diabetes- a chronic disease that affects the way body cells convert food into energy. Diabetes is the seventh leading cause of death by disease
Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions What are the Colon and Rectum? The colon and rectum together make up the large intestine. After
MANAGING ANEMIA When You Have Kidney Disease or Kidney Failure www.kidney.org About the Information in this Booklet Did you know that the National Kidney Foundation (NKF) offers guidelines and commentaries
Scan for mobile link. Ultrasound - Abdomen Ultrasound imaging of the abdomen uses sound waves to produce pictures of the structures within the upper abdomen. It is used to help diagnose pain or distention
What do kidneys normally do? The kidneys function on many levels to maintain homeostasis (internal balance) in the body. The kidneys make urine as well as determining how concentrate or dilute the urine
Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching
CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,
Breast Imaging 1500 East Duarte Road Duarte, CA 91010-3000 800.826.HOPE www.cityofhope.org MED 8116 0607 25M Breast Imaging Benefits of Early Detection One out of eight women in the U.S. will develop breast
LESSON 3.5 WORKBOOK How do cancer cells evolve? In this unit we have learned how normal cells can be transformed so that they stop behaving as part of a tissue community and become unresponsive to regulation.
Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010 This guide has three parts: 1. Information for health professionals 2. Tables
Diagnostic Medical Sonographer Overview The Field - Preparation - Specialty Areas - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations The Field Diagnostic imaging